Most NSCLCs show lower mitotic rates and Ki67 proliferation rates than, for instance, aggressive lymphomas, like diffuse large B-cell lymphoma and Hodgkin lymphoma, or small cell lung cancer. This evidence concerns the gene MKI67 and lymphoma.